Section: Newark Beth Israel Medical Center News

Pioneering Cardiac Surgeon, Dr. Victor Parsonnet Nominated for Induction into the 2017 New Jersey Hall of Fame


Nominations, are Open for Public Voting from Now through November 26

Dr. Victor ParsonnetNewark, New Jersey – The New Jersey Hall of Fame recently announced its nominees for the class of 2017 and listed Dr. Victor Parsonnet, a Newark native, on the ballot as a worthy New Jerseyan. Public voting is open through November 26 at the New Jersey Hall of Fame website. To vote in support of Dr. Victor Parsonnet’s selection into the New Jersey Hall of Fame visit

“We are forever indebted to Dr. Victor Parsonnet for his dedication to our patients, this community and to advancements in cardiac research. He paved the way for our current success as one of the most comprehensive cardiac programs in the country,” said Darrell K. Terry, Sr., President and CEO, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.

The former Director of Surgery and Surgical Research at Newark Beth Israel Medical Center, 93-year-old Dr. Victor Parsonnet is one of 50 nominees for the New Jersey Hall of Fame Academy, Class of 2017.

A Newark native, Dr. Victor Parsonnet made his name in New Jersey and worldwide as a groundbreaking cardiac surgeon. He was a physician leader and researcher at Newark Beth Israel Medical Center for more than 60 years where he performed the first heart transplants and kidney transplants in New Jersey; he implanted the first permanent pacemakers in New Jersey and the first permanent transvenous pacemakers worldwide.

In addition, he established New Jersey’s first heart transplant program. The Heart Failure Treatment and Transplant program at Newark Beth Israel just celebrated reaching a milestone 1,000 heart transplants performed, a distinction held by only 11 other hospitals nationwide.

The general public is encouraged to cast their vote from November 1- November 26, 2017. The individuals with the most votes in each category are automatically inducted into the New Jersey Hall of Fame. Dr. Victor Parsonnet is one of 10 finalists in the Enterprise category. To cast your vote for Dr. Victor Parsonnet go to

In addition to his many clinical accomplishments, Dr. Parsonnet is an avid lover of the performing arts and served as chairman of the New Jersey Symphony Orchestra for 17 years. He was an early supporter of the creation of the New Jersey Performing Arts Center, and a pianist and avid tennis player.

About Newark Beth Israel Medical Center
Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is a 665-bed regional care teaching hospital that provides comprehensive health care. Newark Beth Israel is home to one of the nation’s top five heart transplant centers, RWJBarnabas Health’s Heart Failure Treatment and Transplant Program; New Jersey’s only Advanced Lung Disease and Transplant Program and a Valve Center that performs more cardiac valve procedures, including minimally invasive transcatheter aortic valve replacements (TAVRs), than any other center in the state. The Newark Beth Israel robotic surgery program is the most experienced in northern New Jersey. The Frederick B. Cohen, MD, Cancer and Blood Disorders Center and the new Healthcare Foundation of New Jersey Breast Health Center provide seamless integration of cancer prevention, specialized care and treatment options. Newark Beth Israel also offers many preventive health programs that promote wellness in the community.

Children’s Hospital of New Jersey (CHoNJ), located at Newark Beth Israel Medical Center, cares for children from birth through adolescence, with more than 30 specialized pediatric services including New Jersey’s largest Valerie Fund Children’s Center for Cancer and Blood Disorders; and the Children’s Heart Center that offers a complete range of medical and surgical treatments for the most complex cardiac abnormalities. Children’s Hospital of New Jersey also includes a Neonatal Intensive Care Unit and a Level IV Regional Perinatal Center that offers New Jersey’s only Extracorporeal Membrane Oxygenation (ECMO) therapy; and the highest level of intensive care for both mothers and newborns.

Categories: Press Releases